GlassScriptPhysician profile
Anushree Sharma
NPI 1104116318
$1,391.65
in general payments reported to CMS, 2019-2025
20 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $39.19 · 2021: $186 · 2022: $122 · 2023: $359 · 2024: $462 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $176.36 | 2019-2023 | Simbrinza |
| Ocular Therapeutix, INC. | $168.11 | 2021-2025 | Dextenza |
| Sight Sciences, INC. | $148.79 | 2023 | Tearcare System |
| Biotissue Holdings INC. | $116.78 | 2023-2024 | |
| Tearlab Corp | $108.38 | 2024 | Scoutpro Osmolarity System |
| Novartis Pharmaceuticals Corporation | $106.67 | 2020-2023 | |
| Bausch & Lomb Americas INC. | $105.15 | 2023-2024 | Miebo, Xiidra, Prolensa |
| Harrow Eye, LLC | $89.20 | 2024-2025 | Vevye |
| Johnson & Johnson Surgical Vision, INC. | $54.56 | 2022 | |
| Rayner Intraocular Lenses Limited | $52.82 | 2024 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Amgen INC. | $39.33 | 2024-2025 | Tepezza |
| Dompe US, INC. | $37.09 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $33.73 | 2022 | |
| Horizon Therapeutics Plc | $33.40 | 2023 | Tepezza |
| Oyster Point Pharma, INC. | $28.82 | 2023 | Tyrvaya |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $22.39 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.19 | 2021 | |
| Omeros Corporation | $19.98 | 2019 | |
| Thea Pharma INC. | $18.20 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $11.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anushree Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.